Iron deficiency (using ferritin concentrations) · children under 12 years of age
It is very uncertain whether intermittent use of iron supplements changes iron deficiency (using ferritin concentrations) compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Iron status (ferritin concentrations in ng/mL) · children under 12 years of age
Intermittent use of iron supplements may leads to higher iron status (ferritin (μg/L) compared with placebo or no intervention (low certainty).
1 finding from 1 review
Iron deficiency anaemia · children under 12 years of age
1 finding from 1 review
All‐cause mortality · children under 12 years of age
1 finding from 1 review
Cure · Children with TB1
It is very uncertain whether intermittent short‐course anti‐TB regimens changes cure compared with daily anti‐TB regimens (very low certainty).
1 finding from 1 review
Death from any cause · Children with TB1
It is very uncertain whether intermittent short‐course anti‐TB regimens changes death from any cause compared with daily anti‐TB regimens (very low certainty).
1 finding from 1 review
Relapse · Children with TB1
It is very uncertain whether intermittent short‐course anti‐TB regimens changes relapse compared with daily anti‐TB regimens (very low certainty).
1 finding from 1 review
Adherence · Children with TB1
It is very uncertain whether intermittent short‐course anti‐TB regimens changes adherence to treatment compared with daily anti‐TB regimens (very low certainty).
1 finding from 1 review
Treatment‐limiting adverse events · Children with TB1
It is very uncertain whether intermittent short‐course anti‐TB regimens changes treatment‐limiting adverse events compared with daily anti‐TB regimens (very low certainty).
1 finding from 1 review
Relapse · patients with schizophrenia
INTERMITTENT (GRADUALLY INCREASED DRUG‐FREE PERIODS) may leads to higher relapse: long term (+ 26 weeks) as defined in each study compared with MAINTENANCE THERAPY (low certainty).
1 finding from 1 review
Hospital admissions · patients with schizophrenia
1 finding from 1 review
Global state: average score: long term (+ 26 weeks) Global Assessment Scale (GAS). Scale from: 0 to 100. · patients with schizophrenia
1 finding from 1 review
Mental state · patients with schizophrenia
1 finding from 1 review
Adverse effects: tardive dyskinesia: long term (+ 26 weeks) as defined in each study · patients with schizophrenia
1 finding from 1 review
Cost‐effectiveness · patients with schizophrenia
1 finding from 1 review
Leaving the study early/ loss to · patients with schizophrenia
It is very uncertain whether INTERMITTENT (GRADUALLY INCREASED DRUG‐FREE PERIODS) changes leaving the study early/ loss to compared with MAINTENANCE THERAPY (very low certainty).
1 finding from 1 review
Respiratory failure post extubation · preterm neonates after extubation
Nasal intermittent positive pressure ventilation (NIPPV) probably leads to lower respiratory failure postextubation compared with nasal continuous positive airway pressure (NCPAP) (moderate certainty).
1 finding from 1 review
Reintubation · preterm neonates after extubation
Nasal intermittent positive pressure ventilation (NIPPV) probably leads to lower endotracheal reintubation compared with nasal continuous positive airway pressure (NCPAP) (moderate certainty).
1 finding from 1 review
Gastrointestinal perforation · preterm neonates after extubation
Nasal intermittent positive pressure ventilation (NIPPV) showed no clear difference in gastrointestinal perforation compared with nasal continuous positive airway pressure (NCPAP) (low certainty).
1 finding from 1 review
Necrotising enterocolitis · preterm neonates after extubation
Nasal intermittent positive pressure ventilation (NIPPV) showed no clear difference in necrotising enterocolitis compared with nasal continuous positive airway pressure (NCPAP) (moderate certainty).
1 finding from 1 review